Promise of Additional Lupus Therapies Highlighted at ACR 2021 Annual Meeting
November 9, 2021
Results of clinical trials testing many existing and potential lupus treatments were highlighted at the American College...
anifrolumab
Important Message from CEO Kenneth Farber: U.S. FDA Approves New Lupus Treatment
August 2, 2021
Dear Friend of the Lupus Research Alliance,
As we reported this morning, the lupus community has much to...
Lupus Research Alliance Applauds U.S. FDA Approval of AstraZeneca’s anifrolumab-fnia (Saphnelo™) for Systemic Lupus Erythematosus (SLE)
First in New Class of Drugs in More than a Decade for SLE Targeting Type 1 Interferons
NEW YORK, NY....
Lupus Research Lifted Up in Everyday Health
May 27, 2021
Funding innovative research year-round is the most meaningful way the Lupus Research Alliance Lifts Up Lupus with...
LRA Welcomes Positive Results with Anifrolumab for Reducing Lupus Flares
May 13, 2021
A new study analyzing data from two large clinical trials showed that the investigational therapy anifrolumab reduced...
Promising New Lupus Treatments Highlighted ACR Annual Meeting
Results of clinical trials testing potential lupus treatments were highlighted at the American College of Rheumatology’s annual meeting ACR...
LRA Highlights Full Continuum of Lupus Research at ACR Convergence 2020
30+ presentations of studies funded by the Lupus Research Alliance on a variety of immune pathways
Results from...
LRA-Supported Study Discovers How Harmful Immune Cells Develop
August 17, 2020
In a new study published in the journal Immunity, Lupus Research Alliance-funded researcher Dr. Boris Reizis and...
Promising News from Major Medical Meeting, EULAR
Updated June 5, 2020
One of the largest meetings for rheumatologists went virtual this year to enable scientists from around...
LRA Congratulates AstraZeneca on Positive Data on Anifrolumab Presented at Major Medical Meeting
June 3, 2020
The Lupus Research Alliance (LRA) is encouraged by positive data from two studies presented at the European...
LRA Celebrates Major Research Breakthroughs in 2019
January 7, 2020
2019 was a phenomenal, breakthrough year for lupus research on both the clinical development and basic science...
Positive Results on Anifrolumab for Lupus Published in New England Journal of Medicine
December 18, 2019
The Lupus Research Alliance (LRA) welcomes additional positive results published today in the New England Journal of...